A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

Novo Nordisk’s icodec-abae is now approved in the US for type 2 diabetes only, after a prior rejection partly due to concerns about hypoglycemia in type 1 diabetes.

The FDA’s decision is based on data from the ONWARDS Phase IIIa clinical programme involving nearly 2,680 adults.

Key Price Increases in Pakistan Medicine prices in Rawalpindi’s Bohar Bazaar have increased by 50% to 500%. The price of insulin injection devices rose from 2,200 PKR to 4,720 P ...

The FDA has approved the first weekly insulin shot for adults with type 2 diabetes, offering a new alternative to daily injections.

Some patients with type 2 diabetes will be able to switch from daily insulin injections to this first-of-its-kind once-weekly alternative.

The FDA approved insulin icodec (Awiqli) as the first once-weekly, long-acting basal insulin for glycemic control in adults ...

A Connecticut college studies with Type 1 diabetes calls for broader social understanding of chronic health conditions.

FDA approves 1st weekly basal insulin, Awiqli, offering adults with Type 2 diabetes a once-weekly injection to improve ...

The FDA approved a once-weekly, long-acting basal insulin for adults with type 2 diabetes as an alternative to daily basal ...

GLP-1 drugs like Ozempic have become massively popular for their slimming side effects, but understanding of their effects is ...